{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:51:38Z","timestamp":1795107098962,"version":"4.10.3"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/md.0000000000002143","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T18:31:56Z","timestamp":1449081116000},"page":"e2143","source":"Crossref","is-referenced-by-count":83,"title":["Early Statin Use and the Progression of Alzheimer Disease"],"prefix":"10.1097","volume":"94","author":[{"given":"Feng-Cheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Shiuan","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei-Fen","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Kuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tsang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-66-20210226","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/archneur.59.11.1764","article-title":"Survival following a diagnosis of Alzheimer disease.","volume":"59","author":"Brookmeyer","year":"2002","journal-title":"Arch Neurol"},{"key":"R3-66-20210226","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1242\/jcs.113.11.1857","article-title":"Proteolytic processing and cell biological functions of the amyloid precursor protein.","volume":"113","author":"De Strooper","year":"2000","journal-title":"J Cell Sci"},{"key":"R4-66-20210226","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(05)70248-9","article-title":"Cholesterol in Alzheimers disease.","volume":"4","author":"Shobab","year":"2005","journal-title":"Lancet Neurol"},{"key":"R5-66-20210226","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/01.wnl.0000288181.00826.63","article-title":"Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.","volume":"70","author":"Arvanitakis","year":"2008","journal-title":"Neurology"},{"key":"R6-66-20210226","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jns.2009.02.352","article-title":"Therapeutic potential of statins in Alzheimers disease.","volume":"283","author":"Kandiah","year":"2009","journal-title":"J Neurol Sci"},{"key":"R8-66-20210226","doi-asserted-by":"crossref","first-page":"e98326","DOI":"10.1371\/journal.pone.0098326","article-title":"A short-term effect of low-dose aspirin on major hemorrhagic risks in primary prevention: a case-crossover design.","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"R9-66-20210226","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djp467","article-title":"Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.","volume":"102","author":"Lai","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R12-66-20210226","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/pds.1062","article-title":"An application of propensity score matching using claims data.","volume":"14","author":"Seeger","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R13-66-20210226","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/EDE.0000000000000069","article-title":"Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments.","volume":"25","author":"Patorno","year":"2014","journal-title":"Epidemiology"},{"key":"R14-66-20210226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/nbdi.2001.0470","article-title":"Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains.","volume":"9","author":"Wahrle","year":"2002","journal-title":"Neurobiol Dis"},{"key":"R15-66-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimers disease.","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"R16-66-20210226","first-page":"1479","article-title":"Can statins put the brakes on Alzheimers disease Expert Opin Investig D","volume":"15","author":"Whitfield","year":"2006","journal-title":"rugs"},{"key":"R17-66-20210226","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0735-1097(98)00514-2","article-title":"Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions.","volume":"33","author":"Kaesemeyer","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R18-66-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2011-110524","article-title":"Statins: the role in the treatment and prevention of Alzheimers neurodegeneration.","volume":"27","author":"Pac-Soo","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"R19-66-20210226","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","article-title":"Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.","volume":"230","author":"Wang","year":"2011","journal-title":"Exp Neurol"},{"key":"R20-66-20210226","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.59.2.223","article-title":"Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.","volume":"59","author":"Rockwood","year":"2002","journal-title":"Arch Neurol"},{"key":"R21-66-20210226","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1532-5415.2010.02906.x","article-title":"Age-varying association between statin use and incident Alzheimers disease.","volume":"58","author":"Li","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"R22-66-20210226","first-page":"74","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.","volume":"23","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"R23-66-20210226","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"R24-66-20210226","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jgs.12414","article-title":"Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment.","volume":"61","author":"Steenland","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"R25-66-20210226","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/JAD-2006-10408","article-title":"Effect of statins on Alzheimers disease biomarkers in cerebrospinal fluid.","volume":"10","author":"Riekse","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"R26-66-20210226","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000095679","article-title":"Statins of different brain penetrability differentially affect CSF PLTP activity.","volume":"22","author":"Vuletic","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R27-66-20210226","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.","volume":"80","author":"Haag","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R28-66-20210226","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archneurol.2011.242","article-title":"Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.","volume":"68","author":"Shepardson","year":"2011","journal-title":"Arch Neurol"},{"key":"R29-66-20210226","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.002","article-title":"Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study.","volume":"21","author":"Bettermann","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R30-66-20210226","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/joim.12262","article-title":"Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis.","volume":"277","author":"Wu","year":"2015","journal-title":"J Intern Med"},{"key":"R31-66-20210226","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archneurol.2011.203","article-title":"Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.","volume":"68","author":"Shepardson","year":"2011","journal-title":"Arch Neurol"},{"key":"R32-66-20210226","first-page":"150","article-title":"Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT.","volume":"15","author":"Alves","year":"2005","journal-title":"J Neuroimaging"},{"key":"R33-66-20210226","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.20493","article-title":"Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study.","volume":"57","author":"Ruitenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"R34-66-20210226","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-2009-1011","article-title":"Risk of incident Alzheimers disease in diabetic patients: a systematic review of prospective trials.","volume":"16","author":"Kopf","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"R35-66-20210226","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-2011-101392","article-title":"Dementia, diabetes, Alzheimers disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics.","volume":"25","author":"Kuljis","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"R37-66-20210226","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(14)61122-3","article-title":"More multiarm randomised trials of superiority are needed.","volume":"384","author":"Parmar","year":"2014","journal-title":"Lancet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000002143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T02:40:58Z","timestamp":1653705658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201511240-00066"}},"subtitle":["A Total Population-Based Case-Control Study"],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":32,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002143","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}